Back to Journals » International Journal of Nanomedicine » Volume 10 » Issue 1

Empirical modeling of the fine particle fraction for carrier-based pulmonary delivery formulations

Authors Pacławski A, Szlęk J, Lau R, Jachowicz R, Mendyk A

Received 15 October 2014

Accepted for publication 13 November 2014

Published 21 January 2015 Volume 2015:10(1) Pages 801—810

DOI https://doi.org/10.2147/IJN.S75758

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Editor who approved publication: Prof. Dr. Thomas J Webster


Video abstract presented by Adam Pacławski

Views: 349

Adam Pacławski,1 Jakub Szlęk,1 Raymond Lau,2 Renata Jachowicz,1 Aleksander Mendyk1

1Department of Pharmaceutical Technology and Biopharmaceutics, Jagiellonian University Medical College, Kraków, Poland; 2School of Chemical and Biomedical Engineering, College of Engineering, Nanyang Technological University, Singapore

Abstract: In vitro study of the deposition of drug particles is commonly used during development of formulations for pulmonary delivery. The assay is demanding, complex, and depends on: properties of the drug and carrier particles, including size, surface characteristics, and shape; interactions between the drug and carrier particles and assay conditions, including flow rate, type of inhaler, and impactor. The aerodynamic properties of an aerosol are measured in vitro using impactors and in most cases are presented as the fine particle fraction, which is a mass percentage of drug particles with an aerodynamic diameter below 5 µm. In the present study, a model in the form of a mathematical equation was developed for prediction of the fine particle fraction. The feature selection was performed using the R-environment package “fscaret”. The input vector was reduced from a total of 135 independent variables to 28. During the modeling stage, techniques like artificial neural networks, genetic programming, rule-based systems, and fuzzy logic systems were used. The 10-fold cross-validation technique was used to assess the generalization ability of the models created. The model obtained had good predictive ability, which was confirmed by a root-mean-square error and normalized root-mean-square error of 4.9 and 11%, respectively. Moreover, validation of the model using external experimental data was performed, and resulted in a root-mean-square error and normalized root-mean-square error of 3.8 and 8.6%, respectively.

Keywords: fine particle fraction, pulmonary delivery, deposition modeling, genetic programming, feature selection, empirical modeling

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]